Amgen Shareholders Appeal ERISA Loss To 9th Circ.
Employee shareholders have decided to appeal a federal judge's dismissal of their putative class action against Amgen Inc. over alleged drug safety concerns and illegal marketing that sent the biotechnology company's...To view the full article, register now.
Already a subscriber? Click here to view full article